Senior insider sale
Chief Medical Officer at SOPHIA GENETICS SA — senior position signals high conviction
$201.9K
41.38K shares
MENU PHILIPPE plans to sell 41.38K shares of SOPHIA GENETICS SA valued at approximately $201.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Units
N/A
Restricted Stock Units
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/18/2026 | Restricted Stock Units N/A | 608.00 | — |
1/3/2025 | Restricted Stock Units N/A | 10K | — |
| Total | 10.61K | ||
Completed
Units to sell
1.60K
Market value
$7.9K
Units to sell
4.40K
Market value
$21.0K
Units to sell
3.73K
Market value
$17.4K
Units to sell
1.93K
Market value
$9.2K
Units to sell
2.80K
Market value
$13.5K
Units to sell
2.40K
Market value
$11.7K
Units to sell
2.70K
Market value
$13.1K
Units to sell
608.00
Market value
$2.9K
Units to sell
5K
Market value
$22.6K
Units to sell
608.00
Market value
$2.9K
Units to sell
5K
Market value
$23.6K
Planned — Approximate Date
Units to sell
10.61K
Market value
$56.0K
Units
41.38K
Value
$201.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/14/2026 | 1.60K | $7.9K | — | Completed |
4/13/2026 | 4.40K | $21.0K | — | Completed |
4/10/2026 | 3.73K | $17.4K | — | Completed |
4/9/2026 | 1.93K | $9.2K | — | Completed |
4/8/2026 | 2.80K | $13.5K | — | Completed |
4/7/2026 | 2.40K | $11.7K | — | Completed |
4/6/2026 | 2.70K | $13.1K | — | Completed |
3/19/2026 | 608.00 | $2.9K | — | Completed |
3/12/2026 | 5K | $22.6K | — | Completed |
2/19/2026 | 608.00 | $2.9K | — | Completed |
2/12/2026 | 5K | $23.6K | — | Completed |
| Planned — Approximate Date | ||||
4/20/2026 | 10.61K | $56.0K | NASDAQ | Planned |
| Total | 41.38K | $201.9K | ||